Testing HbA1c at home: options, accuracy, and next steps
Clinical review pending
How at-home HbA1c tests work, what the thresholds mean, how accuracy varies, and when laboratory follow-up is needed.

Some tests can measure HbA1c at home; others use a sample you collect yourself and send to a laboratory. Either approach can save travel and appointments. An abnormal home result is a reason for medical follow-up, however, rather than a confirmed diabetes diagnosis. Reliability depends on the test method, sample collection, and health conditions that can affect the result.
How does an at-home HbA1c test work?
Many home tests use a lancet to collect a small drop of blood from a fingertip. The test measures the proportion of hemoglobin that has glucose attached to it. Known as HbA1c, A1c, or glycated hemoglobin, the result reflects blood sugar exposure over roughly the past two to three months. The most recent weeks have a greater influence than the earlier weeks. Source 1 Source 2
A conventional blood glucose meter answers a different question: it shows the glucose concentration at the time of measurement. HbA1c summarizes a longer period. A favorable average can therefore hide individual high or low glucose readings. HbA1c cannot detect an acute episode of low blood sugar.
Collecting a sample at home and measuring it at home are also different things. With a mail-in test, the actual analysis happens in a laboratory; an immediate-result device performs the analysis where the sample is collected. Source 1
Three options without a traditional office appointment
Services differ in who collects the sample and where it is measured:
- An immediate-result device for a finger-stick sample. A device designed for this purpose analyzes the sample directly. In the United States, for example, FDA clearance is documented for an A1cNow self-testing system. That clearance does not show that every similarly advertised device has the same accuracy or intended use. Source
- A mail-in kit with laboratory analysis. The sample goes into a tube or onto a designated collection material and is sent to a laboratory. Instructions for blood volume, drying, temperature, and shipping time are part of the measurement procedure. Source
- A self-ordered laboratory blood draw. This uses a venous blood sample. It is not an at-home test, but may be available without a prior office appointment, depending on the service. The study of these direct services concerns US companies; access and rules can differ elsewhere. Source
Reports usually give a percentage, often accompanied by mmol/mol. Interpretation also depends on the method and intended use: a test for monitoring an existing condition is not automatically suitable for a first diagnosis.
What does the result mean?
Commonly used HbA1c categories for assessing diabetes risk outside pregnancy are:
| Category | HbA1c | Meaning |
|---|---|---|
| Below the prediabetes range | Below 5.7 percent | Not elevated by these HbA1c thresholds; other signs of diabetes may still be present |
| Prediabetes range | 5.7 to 6.4 percent | Increased risk of type 2 diabetes, especially toward the upper end |
| Diabetes range | 6.5 percent or higher | Suggests a diagnosis that generally needs confirmation with appropriate laboratory testing |
These thresholds correspond to guidance from the NIDDK and the ADA diagnostic recommendations, among others. They are diagnostic categories, not individual treatment targets for people who already have diabetes. Source 1 Source 2
Risk increases gradually; there is no sudden biological dividing line between 5.6 and 5.7 percent. Measurement differences can change the category, especially near a threshold. A low HbA1c also does not reliably rule out diabetes when typical symptoms, elevated glucose readings, or factors that distort HbA1c are present.
How accurate are home tests?
Accuracy varies considerably among products and collection methods. In a study of three commercial home tests in people with diabetes, between 29 and 82 percent of results, depending on the test, were within 5 percent of the laboratory reference value. None reached the study’s target of at least 90 percent. Source 1
“Within 5 percent” means a relative difference from the measured value, not five HbA1c percentage points. A test can therefore differ enough to matter near a diagnostic threshold even when the numbers look similar at first glance.
Standardized laboratory methods have greatly improved the comparability of HbA1c results. Point-of-care devices also need quality control; a certificate alone does not guarantee the same performance under every condition. In an independent evaluation, only 5 of 19 point-of-care devices met both the tested IFCC criteria and NGSP criteria against at least one secondary reference measurement procedure. This selection of devices does not represent every home device available today. Source 1 Source 2 Source 3
The sample material matters, too. In some studies, dried blood samples agreed less closely with venous samples than liquid capillary blood collected in suitable tubes. This does not make all dried blood methods unusable: each procedure needs validation for collection, transport, and analysis. Source 1 Source 2
Which conditions or circumstances can distort HbA1c?
HbA1c depends on more than blood sugar. Red blood cell lifespan and the properties of hemoglobin affect the result. These limitations apply even when laboratory measurement is technically sound.
- Iron deficiency anemia: It can make HbA1c appear higher than the actual glucose exposure would suggest.
- Hemoglobin variants: Some inherited variants interfere with particular measurement methods. Their prevalence varies among populations; what matters is the individual’s variant and the method, not ancestry alone.
- Kidney or liver disease: Results can be harder to interpret, depending on the condition and treatment.
- Pregnancy: Changes in red blood cells and glucose regulation limit what HbA1c can show. Gestational diabetes has its own testing procedures.
- Recent blood loss or a transfusion: These can change the composition and age of circulating blood cells.
The NIDDK, MedlinePlus, and ADA recommendations explain these influences. When HbA1c and measured glucose readings do not agree, a possible explanation of this kind should be investigated. Source 1 Source 2 Source 3
Fructosamine can be an alternative for monitoring in selected situations. It reflects roughly the previous two to three weeks and depends on blood proteins rather than red blood cells. This marker also has limitations, including altered albumin turnover, and does not automatically replace standard diagnostic criteria. Source 1
What should happen after an abnormal home result?
An unexpectedly high home result, or one that does not fit previous readings, should be followed up with an appropriate laboratory test. Depending on the situation, options include another HbA1c, fasting plasma glucose, or an oral glucose tolerance test. HbA1c alone does not require fasting; combined testing may still require a fasting period. Source 1
Marked thirst, frequent urination, unexplained weight loss, or feeling very ill should be assessed without waiting for a later mail-in HbA1c test. Vomiting, deep rapid breathing, or altered consciousness particularly require urgent medical help.
Screening recommendations for people without symptoms differ by country and professional organization. The US ADA recommends screening before age 35 when overweight or obesity is accompanied by additional risk factors; for everyone else, screening starts at 35. With normal results, testing is generally repeated at least every three years, and with prediabetes, annually. The US Preventive Services Task Force focuses its recommendation on adults ages 35 to 70 with overweight or obesity. These are US recommendations; in Germany, individual preventive care should take account of age, risk, and local services. Source 1 Source 2
Measurements under comparable conditions help with monitoring. Frequently switching devices can make interpretation harder. For someone with established diabetes, HbA1c, current glucose readings, possible low blood sugar episodes, and individual treatment goals need to be considered together.
Sources
- Colley J, Dambha-Miller H, Stuart B, et al. Home monitoring of haemoglobin A1c in diabetes: a systematic review and narrative synthesis on accuracy, reliability and patient acceptability. Diabet Med. 2023;40(4):e15033. https://doi.org/10.1111/dme.15033 Source
- MedlinePlus. Hemoglobin A1C (HbA1c) test. National Library of Medicine. Updated May 20, 2025. Accessed October 16, 2026. https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/ Source
- National Institute of Diabetes and Digestive and Kidney Diseases. The A1C test & diabetes. Last reviewed April 2018. Accessed October 16, 2026. https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test Source
- US Food and Drug Administration. 510(k) premarket notification K090413: A1CNow+ (professional use) and A1CNow Self Check (OTC use). Decision date May 14, 2009. Accessed October 16, 2026. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K090413 Source
- Kalokairinou L, Choi R, Wei NY, Wexler A. Policies of US companies offering direct-to-consumer laboratory tests. JAMA Intern Med. 2023;183(11):1275-1278. https://doi.org/10.1001/jamainternmed.2023.4726 Source
- American Diabetes Association Professional Practice Committee for Diabetes. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27-S49. https://doi.org/10.2337/dc26-S002 Source
- Jacobsen LM, Bocchino LE, Lum JW, et al. Accuracy of three commercial home-use hemoglobin A1c tests. Diabetes Technol Ther. 2022;24(11):789-796. https://doi.org/10.1089/dia.2022.0187 Source
- Sacks DB, Kirkman MS, Little RR. Point-of-care HbA1c in clinical practice: caveats and considerations for optimal use. Diabetes Care. 2024;47(7):1104-1110. https://doi.org/10.2337/dci23-0040 Source
- Lenters-Westra E, Singh P, Vetter B, English E. Challenges in Hb A1c point-of-care testing: only 5 of 19 Hb A1c point-of-care devices meet IFCC and NGSP certification criteria on independent evaluation. Clin Chem. 2025;71(7):775-788. https://doi.org/10.1093/clinchem/hvaf059 Source
- Verougstraete N, Lapauw B, Van Aken S, Delanghe J, Stove C, Stove V. Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA1c in diabetes patients. Clin Chem Lab Med. 2017;55(3):462-469. https://doi.org/10.1515/cclm-2016-0411 Source
- Danese E, Montagnana M, Nouvenne A, Lippi G. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol. 2015;9(2):169-176. https://doi.org/10.1177/1932296814567227 Source
- US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(8):736-743. https://doi.org/10.1001/jama.2021.12531 Source